FGFR1 and esophageal squamous cell carcinoma: Loga et al. found no association between FGFR1 amplification and clinical outcome of ESCC patients while Kwon et al. showed that FGFR1 amplification was an independent predictor of prolonged OS of ESCC patients [13, 14].